Skip to main content

Table 3 Relationship between MVI severity and HBV-related factors (The HBsAg factor included all 660 patients, and other factors included only HBsAg-positive patients)

From: Effect of hepatitis B virus DNA replication level and anti-HBV therapy on microvascular invasion of hepatocellular carcinoma

HBV-related factors Severity of MVI P
M0 (%) M1 (%) M2 (%)
HBsAg Positive 297 (84.6) 155 (88.6) 126 (94.0) 0.017
Negative 54 (15.4) 20 (11.4) 8 (6.0)
HBV DNA > 100 IU/ml 145 (48.8) 82 (52.9) 84 (68.3) 0.001
<=100 IU/ml 152 (51.2) 73 (47.1) 39 (31.7)
Presence of cirrhosis Yes 191 (64.3) 124 (0.80) 77 (62.6) 0.001
No 106 (35.7) 31 (0.20) 46 (37.4)
Antivirus treatment Yes 102 (34.3) 41 (26.4) 31 (25.2) 0.021
No 195 (65.7) 114 (73.6) 92 (74.8)